Isoquinoline derivatives as calpain inhibitors

Details Isoquinoline derivatives as calpain inhibitors Isoquinoline derivatives as calpain inhibitors

2011-04-26

2011-04-26

Davis, Zinna N (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S309000, C546S140000, C546S141000

Reexamination Certificate

active

07932266

ABSTRACT:
The invention relates to derivative compounds of partially-reduced isoquinoline with substitution of a sec-butyl group at position 3 with calpain inhibitor activity. The inventive compound comprises an ester or amide derived from (3-sec-butyl-1-oxo-2,3-dihydro-1H-isoquinolin-4-yliden)-acetic acid and (3-sec-butyl-1-thioxo-2, 3-dihydro-1H-isoquinolin-4-yliden)-acetic acid. Compounds having formula I or II can be used in the preventive or therapeutic treatment of a degenerative disease.

REFERENCES:
patent: 5541290 (1996-07-01), Harbeson et al.
patent: 5576435 (1996-11-01), Melikian-Badalian et al.
patent: 6103720 (2000-08-01), Lubisch et al.
patent: 1 743 883 (2007-01-01), None
patent: 200301125 (2003-05-01), None
patent: 200401104 (2004-05-01), None
patent: 96/41638 (1996-12-01), None
patent: 2004/101494 (2004-11-01), None
Kevin K.W. Wang et al., “Development and Therapeutic Potential of Calpain Inhibitors”, Adv. Pharmacol., vol. 37, pp. 117-152 (1996).
Shoji Hata et al., “Domain II of m-calpain is a Ca2+-dependent cysteine protease”, FEBS Letters, vol. 501, pp. 111-114 (2001).
Tatiana G. Sazontova et al. “Calpains: physiological and pathophysioloqical significance”, Pathophysiology, vol. 6, pp. 91-102 (1999).
Swapan K. Ray et al., “Calpain in the pathophysiology of spinal cord injury: neuroprotection with calpain inhibitors”, Brain Research Reviews, vol. 42, pp. 169-185 (2003).
Frank J.E. Vajda “Neuroprotection and neurodegenerative disease”, Journal of Clinical Neuroscience, vol. 9(1), pp. 4-8 (2002).
Adam Doble, “The Role of Excitotoxicity in Neurodegenerative Disease: Implications for Therapy”, Pharmacol. Ther., vol. 81, No. 3, pp. 163-221 (1999).
Paolo Calabresi et al. “Ionotropic glutamate receptors: still a target for neuroprotection in brain ischemia? Insights from in vitro studies”, Neurobiology of Disease, vol. 12, pp. 82-88 (2003).
Ivy Carroll et al., “Pharmacological properties of JDTic: a novel K-opioid receptor antagonist”, European Journal of Pharmacology, vol. 501, pp. 111-119 (2004).
Arnaud LeTiran et al., “Design and Evaluation of Affinity Labels of Functionalized Amino Acid Anticonvulsants”, J. Med. Chem., vol. 45, pp. 4762-4773 (2002).
Geraldine C.B. Harriman et al., “Cell Adhesion Antagonists: Synthesis and Evaluation of a Novel Series of Phenylalanine Based Inhibitors”, Bioorganic & Medical Chemistry Letters, vol. 10, pp. 1497-1499 (2000).
Yuanhui Huang et al., “The calpain family and human disease”, TRENDS in Molecular Medicine, vol. 7, No. 8, pp. 355-362 (2001).
Ana Montero et al., “Studies on aromatic compounds: inhibition of calpain I by biphenyl derivatives and peptide-biphenyl hybrids”, Bioorganic & Medical Chemistry Letters, vol. 14, pp. 2753-2757 (2004).
Ann Montero et al.,Peptide-Biphenyl Hybrids as Calpain Inhibitors1), Chemistry & Biodiversity, vol. 1, pp. 442-457 (2004).
Enrique Mann et al., “Novel Peptide-Heterocycle Hybrids: Synthesis and Preliminary Studies on Calpain Inhibition”, Adv. Synth. Catal., vol. 344, No. 8, pp. 855-867 (2002).
Paul Lloyd-Williams et al., “Chemical Approaches to the Synthesis of Peptides and Proteins”, New Directions in Organic and Biological Chemistry, CRC Press, Boca Raton (1997)—Table of Contents.
B.M. Frost et al., “Selectivity, Strategy and Efficiency in Modern Organic Chemistry”, Comprehensive Organic Synthesis—Elsevier, http://www.elsevier.com/wps/find/bookdescription.cws—home/26507/...—Table of Contents, 2006.
Francisco Sánchez-Sancho et al., “Efficient Syntheses of Polyannular Heterocycles Featuring Microwave-Accelerated Bischler-Napieralski Reaction, Stereoselective Heck Cyclization, and Claisen Rearrangement”, Synlett, No. 4, pp. 509-513 (2000).
Francisco Sánchez-Sancho et al., “Efficient Synthesis of Chiral Isoquinoline and Pyrido[1,2-b]-isoquinoline Derivatives via Intramolecular Heck Reactions”, Adv. Synth. Catal., No. 4, pp. 360-368 (2001).
Patrick Metzner “Thiocarbonyl Compounds as Specific Tools for Organic Synthesis”, Topics in Current Chemistry, vol. 204, pp. 127-181 (1999).
S. Scheibye et al., “Studies on Organophosphorus Compounds XXI.* The Dimer of p-Methoxyphenylthionophosphine sulfide as Thiation Reagent. A New Route to Thiocarboxamides”, Bull. Soc. Chim. Belg., vol. 87
°3 (1978).
Francisco Sánchez-Sancho et al., “Short syntheses of(S)-pipecolic acid,(R)-coniine, and(S)-ō-coniceine using biocatalytically-generated chiral building blocks”, Tetrahedron: Asymmetry, vol. 9, pp. 1951-1965 (1998).

Affiliated with

Also associated with

Rating

Isoquinoline derivatives as calpain inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Isoquinoline derivatives as calpain inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isoquinoline derivatives as calpain inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2673837